Synthesis of friedelan triterpenoid analogs with DNA topoisomerase IIα inhibitory activity and their molecular docking studies

Eur J Med Chem. 2012 Aug:54:137-43. doi: 10.1016/j.ejmech.2012.04.037. Epub 2012 May 8.

Abstract

Five highly oxygenated friedelan derivatives (3a, 3b, 4, 5a and 5b) were synthesized. The structures of these compounds were established on the basis of spectral (IR, 1D and 2D NMR, MS etc.) and chemical data. The molecules, including the parent compounds were screened for three-dimensional (3D) molecular docking on the crystal structure of topoisomerase IIα (1 bgw for topoisomerase IIα, PDB). Compounds 3a and 5a showed a dose dependent inhibition of catalytic activity of human topoisomerase IIα.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Neoplasm / chemistry
  • Antigens, Neoplasm / metabolism*
  • Biocatalysis / drug effects
  • Chemistry Techniques, Synthetic
  • DNA Topoisomerases, Type II / chemistry
  • DNA Topoisomerases, Type II / metabolism*
  • DNA-Binding Proteins / antagonists & inhibitors*
  • DNA-Binding Proteins / chemistry
  • DNA-Binding Proteins / metabolism*
  • Humans
  • Molecular Docking Simulation*
  • Protein Conformation
  • Topoisomerase II Inhibitors / chemical synthesis*
  • Topoisomerase II Inhibitors / chemistry
  • Topoisomerase II Inhibitors / metabolism
  • Topoisomerase II Inhibitors / pharmacology*
  • Triterpenes / chemical synthesis*
  • Triterpenes / chemistry
  • Triterpenes / metabolism
  • Triterpenes / pharmacology*

Substances

  • Antigens, Neoplasm
  • DNA-Binding Proteins
  • Topoisomerase II Inhibitors
  • Triterpenes
  • DNA Topoisomerases, Type II